DNAprint Genomics (DNAG)

[Blue Juggernaut]

Bump. 26371

I, like many, have voted No on the R/S. Current funding for this company is fine for the short term. Releasing more shares into the market place (as needed) is a MUCH better option due to the FACT that the pps is so low. The only time I will ever vote for a r/s for this company or any other company is to get on an exchange or to get to a level (~>5.00) where more instituational investors look at you. As I have said before, for DNAP to get on a major exchange the r/s would have to get the price to 3 or 4 (depending on the exchange) due to minimum bid requirements and as of right now the minimum income requirements are too high for DNAP (this is a fact). My reasons are sound and factual to oppose the r/s. For those that are considering voting yes, please do some DD and ask the question WHY does the company want a r/s when it can not get us on an exchange. Please review this matter closely.

Good luck and God bless to all,
Big Blue (DNAP Long-Investor)